#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prolymphocytic leukaemia Leukodystrophy Choroid melanoma Hereditary spastic paraplegia Autoinflammation with infantile enterocolitis Inflammatory myofibroblastic tumour T-cell type acute leukaemia Congenital leptin deficiency Myelodysplastic syndrome with excess blasts Turner's syndrome Arteriosclerosis Anal cancer recurrent Ataxia telangiectasia Acute myeloid leukaemia (in remission) Phenylketonuria More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis Burkitt’s lymphoma – Treatment Progressive multifocal leukoencephalopathy – Basic Information Niemann-Pick disease – Life with Disease Netherton’s syndrome – Treatment Ehlers-Danlos syndrome – Trials in Disease Wolfram syndrome – Life with Disease Mitochondrial myopathy – Life with Disease Primary biliary cholangitis – Diagnostics Ewing’s sarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tirbanibulin Dydrogesterone STREPTOCOCCUS VIRIDANS Eteplirsen Formoterol Fumarate Idarubicin Hydrochloride Tertomotide Cusatuzumab Benzalkonium Chloride Tramadol Ursodeoxycholic Acid Estradiol Hemihydrate Selexipag Metyrapone Bp Atogepant Dl-Alpha-Tocopherol [18F]-Altanserin Abc-23A-116 Gs-1427 Eye103 More therapies…

    Learn about Your Condition

    Lyme disease Metastatic neoplasm Blood disorder Measles Small intestine leiomyosarcoma Micrographic skin surgery Pulmonary venous thrombosis Thrombectomy Glomerulonephritis chronic Post procedural oedema Sinus rhythm Liposarcoma Retinal neovascularisation Gaucher's disease type III Lymphocytic lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. KBC Zagreb

KBC Zagreb

Ulica Mije Kispatica 12, Zagreb, 10000, Croatia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Investigated Drugs:
    • Risankizumab
    Austria Belgium Bulgaria Croatia Czechia France +13

  • Study on the Safety and Effectiveness of MB-CART2019.1 for Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Zamtocabtagene Autoleucel
    • Allopurinol
    • Acalabrutinib
    Croatia Hungary

  • Study on Masupirdine for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Masupirdine
    Croatia Poland

  • Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Atorvastatin
    • Inclisiran
    • Rosuvastatin
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Charcoal, Activated
    • Colestyramine
    • Magnesium Citrate
    Bulgaria Croatia Czechia Estonia France Germany +9

  • Study Comparing Pirtobrutinib with Idelalisib and Rituximab or Bendamustine and Rituximab for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Idelalisib
    • Bendamustine Hydrochloride
    • Pirtobrutinib
    Austria Belgium Croatia Czechia France Germany +5

  • Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    Austria Belgium Bulgaria Croatia Czechia Estonia +14

  • Study on Zetomipzomib for Patients with Active Lupus Nephritis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Lupus nephritis
    Investigated Drugs:
    • Water For Injection
    • Zetomipzomib
    • Methylprednisolone Sodium Succinate
    Croatia France Germany Greece Italy Portugal +1

  • Study on Upadacitinib for Adults and Adolescents with Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure

    Not recruiting

    3 1
    Investigated Diseases:
    • Hidradenitis
    Investigated Drugs:
    • Upadacitinib
    Austria Belgium Bulgaria Croatia Czechia Finland +12

  • Study on Linaclotide for Treating Functional Constipation in Children Aged 6 Months to Less Than 2 Years

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Constipation
    Investigated Drugs:
    • Linaclotide
    Bulgaria Croatia Germany Hungary
Previous Page
1 … 12 13 14 15 16
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!